These PSMA-targeting radioligands can facilitate positron emission tomography/computed tomography (PET/CT) imaging with superior diagnostic performance to conventional imaging techniques, particularly for biochemically recurrent (BCR) PCa patients [4–6]. Here, FOLH1 is linked to posterior cortical atrophy.